Scott Dunseth Myers insider trades
Open-market stock purchases and sales by Scott Dunseth Myers, Director at Zentalis Pharmaceuticals, Inc, from SEC Form 4 filings since Apr 4, 2016.
Track record: 50% of 4 scored buys are up 5% or more since purchase, averaging +31%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 16, 2026 | ZNTL Zentalis Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 10, 2026 | DVAX Dynavax Technologies Corp | Sold (not open market) | — |
| Feb 10, 2026 | DVAX Dynavax Technologies Corp | Sold (not open market) | — |
| Feb 10, 2026 | DVAX Dynavax Technologies Corp | Sold (not open market) | $790K |
| Feb 10, 2026 | DVAX Dynavax Technologies Corp | Sold (not open market) | $197K |
| Feb 10, 2026 | DVAX Dynavax Technologies Corp | Sold (not open market) | $267K |
| Feb 10, 2026 | DVAX Dynavax Technologies Corp | Sold (not open market) | $290K |
Companies traded
- ZNTL Zentalis Pharmaceuticals, Inc: 1 buy, last Jun 16, 2026
- DVAX Dynavax Technologies Corp: 1 buy, last Feb 10, 2026
- HARP Harpoon Therapeutics, Inc: other filings, last Mar 11, 2024
- RNAC Cartesian Therapeutics, Inc: other filings, last Nov 13, 2023
- VRDN Viridian Therapeutics, Inc.\DE: 2 buys, last Apr 12, 2023
- SELB Selecta Biosciences Inc: other filings, last Jan 2, 2023
- TRIL Trillium Therapeutics Inc: other filings, last Nov 17, 2021
- AMAG Amag Pharmaceuticals, Inc: other filings, last Nov 16, 2020
- CASC Cascadian Therapeutics, Inc: 7 buys, last Mar 9, 2018
- ONTY Oncothyreon Inc: other filings, last Apr 4, 2016
Get free alerts when Scott Dunseth Myers files a new trade →